Morbidity, Mortality and use of Medication in Familial Hypercholesterolemia. A Register Study
- Prosjektnummer
- 2012036
- Ansvarlig person
- Kjetil Retterstøl
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cardiovascular
- Forskningsaktivitet
- 3. Prevention
Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death.
Eur Heart J 2016 May 01;37(17):1398-405. Epub 2015 nov 18
PMID: 26586781 - Inngår i doktorgradsavhandlingen
A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries.
Curr Opin Lipidol 2016 Aug;27(4):388-97.
PMID: 27070076
Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study.
Eur J Prev Cardiol 2016 Aug 24. Epub 2016 aug 24
PMID: 27558979 - Inngår i doktorgradsavhandlingen
[Increased mortality in familial hypercholesterolemia].
Tidsskr Nor Laegeforen 2015 Jun 16;135(11):1024-5. Epub 2015 jun 16
PMID: 26080775
Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.
J Am Heart Assoc 2014 Dec;3(6):e001236. Epub 2014 des 2
PMID: 25468658 - Inngår i doktorgradsavhandlingen
Mortality and cardiovascular morbidity in patients with familial hypercholesterolemia. PhD Thesis
Medical Faculty, University of Oslo, DUO vitenarkiv , Open Access, October 2016.Available at: http://urn.nb.no/URN:NBN:no-56160 .
Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992- 2013
Eur J Prev Cardiol 2016, October 29,DOI: 10.1177/2047487316676135
Mortality and cardiovascular morbidity in patients with familial hypercholesterolemia
- Disputert:
- september 2016
- Hovedveileder:
- Kjetil Retterstøl
- Trond Paul Leren Prosjektdeltaker
- Leiv Ose Medveileder
- Kjetil Retterstøl Hovedveileder
- Liv Mundal Doktorgradsstipendiat (finansiert av denne bevilgning)
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport